Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

NCT04425252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Brequinar
OTHER: Standard of Care

Sponsor

Clear Creek Bio, Inc.